Oxybutynin and cognitive dysfunction

BMJ. 1997 Nov 22;315(7119):1363-4. doi: 10.1136/bmj.315.7119.1363.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cholinergic Antagonists / therapeutic use*
  • Cognition Disorders / chemically induced*
  • Confusion / chemically induced
  • Humans
  • Male
  • Mandelic Acids / adverse effects*
  • Parkinson Disease / drug therapy

Substances

  • Cholinergic Antagonists
  • Mandelic Acids
  • oxybutynin